EP1238677A2 — Parenteral fat emulsions comprising edetate as preservative
Assigned to AstraZeneca AB · Expires 2002-09-11 · 24y expired
What this patent protects
Sterile, aqueous oil-in-water emulsions for parenteral administration comprising an amount of edetate sufficient to prevent significant growth of microorganisms for at least 24 hours after adventitious, extrinsic contamination are described; such systems containing a therapeutic …
USPTO Abstract
Sterile, aqueous oil-in-water emulsions for parenteral administration comprising an amount of edetate sufficient to prevent significant growth of microorganisms for at least 24 hours after adventitious, extrinsic contamination are described; such systems containing a therapeutic or pharmaceutical agent are also described, together with methods for preparation and use of all such systems.
Drugs covered by this patent
- Cleviprex (CLEVIDIPINE) · Chiesi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.